• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ZLD

ZELIRA THERAPEUTICS LIMITED - Announcements

7.32% ! 38.0¢
Market Cap $4.520M  !

Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company... Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. It owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets. It is focused on developing and clinically validating branded cannabinoid-based medicines in its prescription (Rx) business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter (OTC) products. It has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The Company in partnership with SprinJeneCBD, introduced a full line of oral care products, including SprinJeneCBD toothpaste product, which is a hemp-derived, oral care products containing cannabinoids, blackseed oil and zinc utilizing patented technology.More

Announcements



Filters [Clear]
  • Price Sensitive: Yes
ZLD December 2020 Quarterly ReportPRICE SENSITIVE29/01/21 download Created with Sketch. 169.32KB
ZLD Zelira Expands HOPE Distribution to Washington DC, USAPRICE SENSITIVE14/12/20 download Created with Sketch. 172.6KB
ZLD R&D Tax Incentive RefundPRICE SENSITIVE11/12/20 download Created with Sketch. 167.46KB
ZLD ZLD Partners with SprinJene to Launch CBD Toothpaste in USPRICE SENSITIVE02/12/20 download Created with Sketch. 229.28KB
ZLD EMD:Emyria Enters Data Deal with ZLD to Support Autism TrialPRICE SENSITIVE09/11/20 download Created with Sketch. 242.2KB
ZLD Emyria Deal and Autism Observational Trial for HOPE ProductsPRICE SENSITIVE09/11/20 download Created with Sketch. 253.16KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE30/10/20 download Created with Sketch. 155.37KB
ZLD September 2020 Quarterly ReportPRICE SENSITIVE30/10/20 download Created with Sketch. 170.75KB
ZLD HOPE launches in Australia after TGA approves releasePRICE SENSITIVE27/10/20 download Created with Sketch. 179.34KB
ZLD Thorney Becomes a Substantial Strategic Investor in ZeliraPRICE SENSITIVE23/09/20 download Created with Sketch. 200.02KB
ZLD Zenivol launches in Australia after TGA approves releasePRICE SENSITIVE16/09/20 download Created with Sketch. 201.99KB
ZLD Zelira Forms Subsidiary to Launch Oral Care Products in USAPRICE SENSITIVE08/09/20 download Created with Sketch. 195.96KB
ZLD Appendix 4E & Financial StatementsPRICE SENSITIVE28/08/20 download Created with Sketch. 1.37MB
ZLD HOPE Range Of Products Launches In LouisianaPRICE SENSITIVE20/08/20 download Created with Sketch. 180.23KB
ZLD ZLD Successfully Completes $8.75M Oversubscribed PlacementPRICE SENSITIVE03/08/20 download Created with Sketch. 152.46KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE30/07/20 download Created with Sketch. 156.45KB
ZLD June 2020 Quarterly ReportPRICE SENSITIVE30/07/20 download Created with Sketch. 245.26KB
ZLD Trading HaltPRICE SENSITIVE29/07/20 download Created with Sketch. 581.11KB
ZLD Zelira Enters Deal to Develop Products For Vascular DiseasesPRICE SENSITIVE22/07/20 download Created with Sketch. 224.23KB
ZLD Trading HaltPRICE SENSITIVE20/07/20 download Created with Sketch. 365.35KB
ZLD Zelira Phase 1 Chronic Pain Trial Meets Clinical EndpointsPRICE SENSITIVE14/07/20 download Created with Sketch. 288.01KB
ZLD TasAlk to Manufacture Zeliras Insomnia and HOPE productsPRICE SENSITIVE26/05/20 download Created with Sketch. 155.63KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE30/04/20 download Created with Sketch. 167.78KB
ZLD March 2020 Quarterly ReportPRICE SENSITIVE30/04/20 download Created with Sketch. 162.06KB
ZLD Insomnia Trial Meets Primary and Secondary EndpointsPRICE SENSITIVE07/04/20 download Created with Sketch. 682.01KB
ZLD Appendix 4D & FY20 Interim Financial ReportPRICE SENSITIVE28/02/20 download Created with Sketch. 995.62KB
ZLD Phase 1 Opioid Reduction Clinical Trial Fully EnrolledPRICE SENSITIVE27/02/20 download Created with Sketch. 160.74KB
ZLD Zelira Meets Primary Endpoints for Insomnia TrialPRICE SENSITIVE19/02/20 download Created with Sketch. 275.92KB
ZLD Trading HaltPRICE SENSITIVE17/02/20 download Created with Sketch. 228.76KB
ZLD Zelira Successfully Completes Capital Raising of $4.6MPRICE SENSITIVE05/02/20 download Created with Sketch. 161.73KB
ZLD Trading HaltPRICE SENSITIVE03/02/20 download Created with Sketch. 192.45KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE31/01/20 download Created with Sketch. 207.02KB
ZLD December 2019 Quarterly ReportPRICE SENSITIVE31/01/20 download Created with Sketch. 126.51KB
ZLD Zelira to Collaborate with the Parkinsons FoundationPRICE SENSITIVE28/01/20 download Created with Sketch. 163.61KB
ZLD Zelira Therapeutics expands HOPE distribution in the U.S.APRICE SENSITIVE04/12/19 download Created with Sketch. 139.89KB
ZLD Ilera Therapeutics Merger Completed and Board ChangesPRICE SENSITIVE02/12/19 download Created with Sketch. 165.2KB
ZLD Agreement with Health House to Distribute Zelda ProductsPRICE SENSITIVE21/11/19 download Created with Sketch. 212.12KB
ZLD Formulations to be supplied as part of CARE NSW trialPRICE SENSITIVE14/11/19 download Created with Sketch. 160.54KB
ZLD R&D Tax Incentive RefundPRICE SENSITIVE11/11/19 download Created with Sketch. 108.66KB
ZLD Zeldas Phase II Insomnia Clinical Trial Fully EnrolledPRICE SENSITIVE07/11/19 download Created with Sketch. 175.64KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE31/10/19 download Created with Sketch. 203.39KB
ZLD September 2019 Quarterly ReportPRICE SENSITIVE31/10/19 download Created with Sketch. 167.65KB
ZLD Zelda to merge with US-based Ilera TherapeuticsPRICE SENSITIVE09/10/19 download Created with Sketch. 223.68KB
ZLD Trading HaltPRICE SENSITIVE08/10/19 download Created with Sketch. 409.99KB
ZLD Pause in TradingPRICE SENSITIVE08/10/19 download Created with Sketch. 117.26KB
ZLD Appendix 4E & Financial StatementsPRICE SENSITIVE30/08/19 download Created with Sketch. 1.81MB
ZLD Zeldas Autism Observational Study Recruits 100th ParticipantPRICE SENSITIVE22/08/19 download Created with Sketch. 135KB
ZLD June 2019 Quarterly ReportPRICE SENSITIVE31/07/19 download Created with Sketch. 154.04KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE31/07/19 download Created with Sketch. 203.12KB
ZLD Zelda Collaborates with Emerald ClinicsPRICE SENSITIVE18/07/19 download Created with Sketch. 168.44KB
ZLD Response to ASX Price and Volume QueryPRICE SENSITIVE11/07/19 download Created with Sketch. 301.05KB
ZLD Zelda Granted Approval for Opioid Reduction TrialPRICE SENSITIVE02/07/19 download Created with Sketch. 163.14KB
ZLD R&D Tax Incentive RefundPRICE SENSITIVE09/05/19 download Created with Sketch. 133.86KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE30/04/19 download Created with Sketch. 178.66KB
ZLD March 2019 Quarterly ReportPRICE SENSITIVE30/04/19 download Created with Sketch. 125.03KB
ZLD Zelda Partners with Ilera HealthCarePRICE SENSITIVE12/03/19 download Created with Sketch. 168.8KB
ZLD Aus Patent For Novel Prognostic Marker for Breast CancerPRICE SENSITIVE06/03/19 download Created with Sketch. 171.55KB
ZLD Appendix 4D & FY19 Interim Financial ReportPRICE SENSITIVE22/02/19 download Created with Sketch. 1.07MB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE30/01/19 download Created with Sketch. 160.1KB
ZLD December 2018 Quarterly Report and Board TransitionPRICE SENSITIVE30/01/19 download Created with Sketch. 199.72KB
ZLD Response to ASX Price and Volume QueryPRICE SENSITIVE08/01/19 download Created with Sketch. 297.5KB
ZLD ZLD to Invest in Development of Oral Spray FormulationsPRICE SENSITIVE06/12/18 download Created with Sketch. 165.27KB
ZLD SUD: SUDA Enters Agreement To Develop Cannabinoid SprayPRICE SENSITIVE06/12/18 download Created with Sketch. 157.53KB
ZLD Opioid reduction clinical trial with St Vincent's HospitalPRICE SENSITIVE26/11/18 download Created with Sketch. 131.23KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE31/10/18 download Created with Sketch. 160.02KB
ZLD September 2018 Quarterly ReportPRICE SENSITIVE31/10/18 download Created with Sketch. 228.73KB
ZLD Zelda Focuses Clinical Trial ActivityPRICE SENSITIVE11/10/18 download Created with Sketch. 157.83KB
ZLD US Autism Observational Study UnderwayPRICE SENSITIVE10/10/18 download Created with Sketch. 221.44KB
ZLD First Patient Dosed in Zelda Insomnia TrialPRICE SENSITIVE26/09/18 download Created with Sketch. 121.51KB
ZLD Zelda Forms New Partnership to Access German MarketPRICE SENSITIVE04/09/18 download Created with Sketch. 142.53KB
ZLD Appendix 4E & Financial StatementsPRICE SENSITIVE31/08/18 download Created with Sketch. 953.66KB
ZLD June 2018 Quarterly ReportPRICE SENSITIVE30/07/18 download Created with Sketch. 126.27KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE30/07/18 download Created with Sketch. 75.55KB
ZLD Commencement of New Managing DirectorPRICE SENSITIVE16/07/18 download Created with Sketch. 159.29KB
ZLD Appointment of Managing DirectorPRICE SENSITIVE22/05/18 download Created with Sketch. 124.53KB
ZLD March 2018 Quarterly ReportPRICE SENSITIVE30/04/18 download Created with Sketch. 135.38KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE30/04/18 download Created with Sketch. 75.01KB
ZLD Insomnia Clinical Trial Update-Patient Recruitment CompletedPRICE SENSITIVE23/04/18 download Created with Sketch. 125.51KB
ZLD Expansion of Pancreatic Cancer Research ProgrammePRICE SENSITIVE06/03/18 download Created with Sketch. 145.21KB
ZLD Appendix 4D & FY18 Interim Financial ReportPRICE SENSITIVE27/02/18 download Created with Sketch. 289.5KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE31/01/18 download Created with Sketch. 74.93KB
ZLD Zelda joins with US Children's Hospital for autism studyPRICE SENSITIVE11/12/17 download Created with Sketch. 142.58KB
ZLD Trading HaltPRICE SENSITIVE08/12/17 download Created with Sketch. 364.62KB
ZLD Response to ASX Aware QueryPRICE SENSITIVE05/12/17 download Created with Sketch. 578.75KB
ZLD Australian Regulators Approve Zelda Insomnia Clinical TrialPRICE SENSITIVE29/11/17 download Created with Sketch. 127.02KB
ZLD Response to ASX Price and Volume QueryPRICE SENSITIVE22/11/17 download Created with Sketch. 500.58KB
ZLD Trading HaltPRICE SENSITIVE21/11/17 download Created with Sketch. 308.37KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE31/10/17 download Created with Sketch. 80.31KB
ZLD Successful Results in Autism Observation TrialPRICE SENSITIVE18/09/17 download Created with Sketch. 122.86KB
ZLD Appendix 4E & Financial StatementsPRICE SENSITIVE31/08/17 download Created with Sketch. 822.26KB
ZLD Expansion of Breast Cancer Research CollaborationPRICE SENSITIVE31/07/17 download Created with Sketch. 697.38KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE28/07/17 download Created with Sketch. 75.61KB
ZLD ENT:Acquisition of prospective Au& Cu/Zn Murchison TenementsPRICE SENSITIVE26/07/17 download Created with Sketch. 1016.08KB
ZLD Zelda Enters into Strategic Agreement with Knop LaboratoriesPRICE SENSITIVE15/06/17 download Created with Sketch. 175.29KB
ZLD Positive Results From Pre-Clinical Breast Cancer StudiesPRICE SENSITIVE02/06/17 download Created with Sketch. 228.16KB
ZLD March 2017 Quarterly ReportPRICE SENSITIVE28/04/17 download Created with Sketch. 405.15KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE28/04/17 download Created with Sketch. 240.11KB
ZLD Clinical Research Programme to Expand to Include AutismPRICE SENSITIVE19/04/17 download Created with Sketch. 431.74KB
ZLD Cleansing ProspectusPRICE SENSITIVE03/04/17 download Created with Sketch. 211.79KB
ZLD Zelda Successfully Completes Capital RaisingPRICE SENSITIVE30/03/17 download Created with Sketch. 77.28KB
ZLD December 2020 Quarterly Report
29/01/21PRICE SENSITIVE download Created with Sketch. 169.32KB
ZLD Zelira Expands HOPE Distribution to Washington DC, USA
14/12/20PRICE SENSITIVE download Created with Sketch. 172.6KB
ZLD R&D Tax Incentive Refund
11/12/20PRICE SENSITIVE download Created with Sketch. 167.46KB
ZLD ZLD Partners with SprinJene to Launch CBD Toothpaste in US
02/12/20PRICE SENSITIVE download Created with Sketch. 229.28KB
ZLD EMD:Emyria Enters Data Deal with ZLD to Support Autism Trial
09/11/20PRICE SENSITIVE download Created with Sketch. 242.2KB
ZLD Emyria Deal and Autism Observational Trial for HOPE Products
09/11/20PRICE SENSITIVE download Created with Sketch. 253.16KB
ZLD Appendix 4C - quarterly
30/10/20PRICE SENSITIVE download Created with Sketch. 155.37KB
ZLD September 2020 Quarterly Report
30/10/20PRICE SENSITIVE download Created with Sketch. 170.75KB
ZLD HOPE launches in Australia after TGA approves release
27/10/20PRICE SENSITIVE download Created with Sketch. 179.34KB
ZLD Thorney Becomes a Substantial Strategic Investor in Zelira
23/09/20PRICE SENSITIVE download Created with Sketch. 200.02KB
ZLD Zenivol launches in Australia after TGA approves release
16/09/20PRICE SENSITIVE download Created with Sketch. 201.99KB
ZLD Zelira Forms Subsidiary to Launch Oral Care Products in USA
08/09/20PRICE SENSITIVE download Created with Sketch. 195.96KB
ZLD Appendix 4E & Financial Statements
28/08/20PRICE SENSITIVE download Created with Sketch. 1.37MB
ZLD HOPE Range Of Products Launches In Louisiana
20/08/20PRICE SENSITIVE download Created with Sketch. 180.23KB
ZLD ZLD Successfully Completes $8.75M Oversubscribed Placement
03/08/20PRICE SENSITIVE download Created with Sketch. 152.46KB
ZLD Appendix 4C - quarterly
30/07/20PRICE SENSITIVE download Created with Sketch. 156.45KB
ZLD June 2020 Quarterly Report
30/07/20PRICE SENSITIVE download Created with Sketch. 245.26KB
ZLD Trading Halt
29/07/20PRICE SENSITIVE download Created with Sketch. 581.11KB
ZLD Zelira Enters Deal to Develop Products For Vascular Diseases
22/07/20PRICE SENSITIVE download Created with Sketch. 224.23KB
ZLD Trading Halt
20/07/20PRICE SENSITIVE download Created with Sketch. 365.35KB
ZLD Zelira Phase 1 Chronic Pain Trial Meets Clinical Endpoints
14/07/20PRICE SENSITIVE download Created with Sketch. 288.01KB
ZLD TasAlk to Manufacture Zeliras Insomnia and HOPE products
26/05/20PRICE SENSITIVE download Created with Sketch. 155.63KB
ZLD Appendix 4C - quarterly
30/04/20PRICE SENSITIVE download Created with Sketch. 167.78KB
ZLD March 2020 Quarterly Report
30/04/20PRICE SENSITIVE download Created with Sketch. 162.06KB
ZLD Insomnia Trial Meets Primary and Secondary Endpoints
07/04/20PRICE SENSITIVE download Created with Sketch. 682.01KB
ZLD Appendix 4D & FY20 Interim Financial Report
28/02/20PRICE SENSITIVE download Created with Sketch. 995.62KB
ZLD Phase 1 Opioid Reduction Clinical Trial Fully Enrolled
27/02/20PRICE SENSITIVE download Created with Sketch. 160.74KB
ZLD Zelira Meets Primary Endpoints for Insomnia Trial
19/02/20PRICE SENSITIVE download Created with Sketch. 275.92KB
ZLD Trading Halt
17/02/20PRICE SENSITIVE download Created with Sketch. 228.76KB
ZLD Zelira Successfully Completes Capital Raising of $4.6M
05/02/20PRICE SENSITIVE download Created with Sketch. 161.73KB
ZLD Trading Halt
03/02/20PRICE SENSITIVE download Created with Sketch. 192.45KB
ZLD Appendix 4C - quarterly
31/01/20PRICE SENSITIVE download Created with Sketch. 207.02KB
ZLD December 2019 Quarterly Report
31/01/20PRICE SENSITIVE download Created with Sketch. 126.51KB
ZLD Zelira to Collaborate with the Parkinsons Foundation
28/01/20PRICE SENSITIVE download Created with Sketch. 163.61KB
ZLD Zelira Therapeutics expands HOPE distribution in the U.S.A
04/12/19PRICE SENSITIVE download Created with Sketch. 139.89KB
ZLD Ilera Therapeutics Merger Completed and Board Changes
02/12/19PRICE SENSITIVE download Created with Sketch. 165.2KB
ZLD Agreement with Health House to Distribute Zelda Products
21/11/19PRICE SENSITIVE download Created with Sketch. 212.12KB
ZLD Formulations to be supplied as part of CARE NSW trial
14/11/19PRICE SENSITIVE download Created with Sketch. 160.54KB
ZLD R&D Tax Incentive Refund
11/11/19PRICE SENSITIVE download Created with Sketch. 108.66KB
ZLD Zeldas Phase II Insomnia Clinical Trial Fully Enrolled
07/11/19PRICE SENSITIVE download Created with Sketch. 175.64KB
ZLD Appendix 4C - quarterly
31/10/19PRICE SENSITIVE download Created with Sketch. 203.39KB
ZLD September 2019 Quarterly Report
31/10/19PRICE SENSITIVE download Created with Sketch. 167.65KB
ZLD Zelda to merge with US-based Ilera Therapeutics
09/10/19PRICE SENSITIVE download Created with Sketch. 223.68KB
ZLD Trading Halt
08/10/19PRICE SENSITIVE download Created with Sketch. 409.99KB
ZLD Pause in Trading
08/10/19PRICE SENSITIVE download Created with Sketch. 117.26KB
ZLD Appendix 4E & Financial Statements
30/08/19PRICE SENSITIVE download Created with Sketch. 1.81MB
ZLD Zeldas Autism Observational Study Recruits 100th Participant
22/08/19PRICE SENSITIVE download Created with Sketch. 135KB
ZLD June 2019 Quarterly Report
31/07/19PRICE SENSITIVE download Created with Sketch. 154.04KB
ZLD Appendix 4C - quarterly
31/07/19PRICE SENSITIVE download Created with Sketch. 203.12KB
ZLD Zelda Collaborates with Emerald Clinics
18/07/19PRICE SENSITIVE download Created with Sketch. 168.44KB
ZLD Response to ASX Price and Volume Query
11/07/19PRICE SENSITIVE download Created with Sketch. 301.05KB
ZLD Zelda Granted Approval for Opioid Reduction Trial
02/07/19PRICE SENSITIVE download Created with Sketch. 163.14KB
ZLD R&D Tax Incentive Refund
09/05/19PRICE SENSITIVE download Created with Sketch. 133.86KB
ZLD Appendix 4C - quarterly
30/04/19PRICE SENSITIVE download Created with Sketch. 178.66KB
ZLD March 2019 Quarterly Report
30/04/19PRICE SENSITIVE download Created with Sketch. 125.03KB
ZLD Zelda Partners with Ilera HealthCare
12/03/19PRICE SENSITIVE download Created with Sketch. 168.8KB
ZLD Aus Patent For Novel Prognostic Marker for Breast Cancer
06/03/19PRICE SENSITIVE download Created with Sketch. 171.55KB
ZLD Appendix 4D & FY19 Interim Financial Report
22/02/19PRICE SENSITIVE download Created with Sketch. 1.07MB
ZLD Appendix 4C - quarterly
30/01/19PRICE SENSITIVE download Created with Sketch. 160.1KB
ZLD December 2018 Quarterly Report and Board Transition
30/01/19PRICE SENSITIVE download Created with Sketch. 199.72KB
ZLD Response to ASX Price and Volume Query
08/01/19PRICE SENSITIVE download Created with Sketch. 297.5KB
ZLD ZLD to Invest in Development of Oral Spray Formulations
06/12/18PRICE SENSITIVE download Created with Sketch. 165.27KB
ZLD SUD: SUDA Enters Agreement To Develop Cannabinoid Spray
06/12/18PRICE SENSITIVE download Created with Sketch. 157.53KB
ZLD Opioid reduction clinical trial with St Vincent's Hospital
26/11/18PRICE SENSITIVE download Created with Sketch. 131.23KB
ZLD Appendix 4C - quarterly
31/10/18PRICE SENSITIVE download Created with Sketch. 160.02KB
ZLD September 2018 Quarterly Report
31/10/18PRICE SENSITIVE download Created with Sketch. 228.73KB
ZLD Zelda Focuses Clinical Trial Activity
11/10/18PRICE SENSITIVE download Created with Sketch. 157.83KB
ZLD US Autism Observational Study Underway
10/10/18PRICE SENSITIVE download Created with Sketch. 221.44KB
ZLD First Patient Dosed in Zelda Insomnia Trial
26/09/18PRICE SENSITIVE download Created with Sketch. 121.51KB
ZLD Zelda Forms New Partnership to Access German Market
04/09/18PRICE SENSITIVE download Created with Sketch. 142.53KB
ZLD Appendix 4E & Financial Statements
31/08/18PRICE SENSITIVE download Created with Sketch. 953.66KB
ZLD June 2018 Quarterly Report
30/07/18PRICE SENSITIVE download Created with Sketch. 126.27KB
ZLD Appendix 4C - quarterly
30/07/18PRICE SENSITIVE download Created with Sketch. 75.55KB
ZLD Commencement of New Managing Director
16/07/18PRICE SENSITIVE download Created with Sketch. 159.29KB
ZLD Appointment of Managing Director
22/05/18PRICE SENSITIVE download Created with Sketch. 124.53KB
ZLD March 2018 Quarterly Report
30/04/18PRICE SENSITIVE download Created with Sketch. 135.38KB
ZLD Appendix 4C - quarterly
30/04/18PRICE SENSITIVE download Created with Sketch. 75.01KB
ZLD Insomnia Clinical Trial Update-Patient Recruitment Completed
23/04/18PRICE SENSITIVE download Created with Sketch. 125.51KB
ZLD Expansion of Pancreatic Cancer Research Programme
06/03/18PRICE SENSITIVE download Created with Sketch. 145.21KB
ZLD Appendix 4D & FY18 Interim Financial Report
27/02/18PRICE SENSITIVE download Created with Sketch. 289.5KB
ZLD Appendix 4C - quarterly
31/01/18PRICE SENSITIVE download Created with Sketch. 74.93KB
ZLD Zelda joins with US Children's Hospital for autism study
11/12/17PRICE SENSITIVE download Created with Sketch. 142.58KB
ZLD Trading Halt
08/12/17PRICE SENSITIVE download Created with Sketch. 364.62KB
ZLD Response to ASX Aware Query
05/12/17PRICE SENSITIVE download Created with Sketch. 578.75KB
ZLD Australian Regulators Approve Zelda Insomnia Clinical Trial
29/11/17PRICE SENSITIVE download Created with Sketch. 127.02KB
ZLD Response to ASX Price and Volume Query
22/11/17PRICE SENSITIVE download Created with Sketch. 500.58KB
ZLD Trading Halt
21/11/17PRICE SENSITIVE download Created with Sketch. 308.37KB
ZLD Appendix 4C - quarterly
31/10/17PRICE SENSITIVE download Created with Sketch. 80.31KB
ZLD Successful Results in Autism Observation Trial
18/09/17PRICE SENSITIVE download Created with Sketch. 122.86KB
ZLD Appendix 4E & Financial Statements
31/08/17PRICE SENSITIVE download Created with Sketch. 822.26KB
ZLD Expansion of Breast Cancer Research Collaboration
31/07/17PRICE SENSITIVE download Created with Sketch. 697.38KB
ZLD Appendix 4C - quarterly
28/07/17PRICE SENSITIVE download Created with Sketch. 75.61KB
ZLD ENT:Acquisition of prospective Au& Cu/Zn Murchison Tenements
26/07/17PRICE SENSITIVE download Created with Sketch. 1016.08KB
ZLD Zelda Enters into Strategic Agreement with Knop Laboratories
15/06/17PRICE SENSITIVE download Created with Sketch. 175.29KB
ZLD Positive Results From Pre-Clinical Breast Cancer Studies
02/06/17PRICE SENSITIVE download Created with Sketch. 228.16KB
ZLD March 2017 Quarterly Report
28/04/17PRICE SENSITIVE download Created with Sketch. 405.15KB
ZLD Appendix 4C - quarterly
28/04/17PRICE SENSITIVE download Created with Sketch. 240.11KB
ZLD Clinical Research Programme to Expand to Include Autism
19/04/17PRICE SENSITIVE download Created with Sketch. 431.74KB
ZLD Cleansing Prospectus
03/04/17PRICE SENSITIVE download Created with Sketch. 211.79KB
ZLD Zelda Successfully Completes Capital Raising
30/03/17PRICE SENSITIVE download Created with Sketch. 77.28KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
38.0¢
Change
-0.030(7.32%)
Mkt cap ! $4.520M
Open High Low Value Volume
40.0¢ 42.0¢ 38.0¢ $1.766K 4.48K

Buyers (Bids)

No. Vol. Price($)
3 34234 38.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 5666 1
View Market Depth
Last trade - 15.50pm 15/09/2025 (20 minute delay) ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.